Over the past decade, reactive oxygen species (ROS) and nitric oxide (NO) d
erivatives have been established as physiological modulators of skeletal mu
scle function. This mini-review addresses the roles of these molecules as e
ndogenous regulators of muscle contraction. The article is organized in two
parts. First, established concepts are briefly outlined. This section prov
ides an overview of ROS production by muscle, antioxidant buffers that oppo
se ROS effects, enzymatic synthesis of NO in muscle, the effects of endogen
ous ROS on contractile function, and NO as a contractile modulator. Second,
a selected group of unresolved topics are highlighted. These more controve
rsial issues include putative source(s) of regulatory ROS, the relative imp
ortance of the two NO synthase isoforms constitutively coexpressed by muscl
e fibers, molecular mechanisms of ROS and NO action, and the physiological
relevance of redox regulation. By discussing current questions, as well as
the established paradigm, this article is intended to further debate and st
imulate research in this area.